title: [Therapy for hormone-refractory prostate cancer].
authors.affiliation: Department of Urology, Graduate School of Medicine, Osaka University.
authors.forename: Kazuo
authors.initials: K
authors.lastname: Nishimura
authors.forename: Shiro
authors.initials: S
authors.lastname: Takahara
authors.forename: Norio
authors.initials: N
authors.lastname: Nonomura
authors.forename: Akihiko
authors.initials: A
authors.lastname: Okuyama
mesh_terms: D000728:Androgens; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary; D002986:Clinical Trials as Topic; D004002:Clodronic Acid / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D000077143:Docetaxel; D004961:Estramustine / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D017239:Paclitaxel / Q000008:administration & dosage / Q000031:analogs & derivatives*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D013326:Strontium Radioisotopes / Q000627:therapeutic use; D043823:Taxoids; D005641:Tegafur / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D000728:Androgens; D013326:Strontium Radioisotopes; D043823:Taxoids; D004002:Clodronic Acid; D005641:Tegafur; D000077143:Docetaxel; D004961:Estramustine; D003907:Dexamethasone; D003520:Cyclophosphamide; D017239:Paclitaxel